COF vs PPCB · P/E 62, rev $53.43B vs P/E 0.0, $3.9M cap
Capital One Financial Corporation (COF) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
PPCB does not have a complete income-statement cache yet.
COF currently screens at market cap $125.00B and trailing P/E 61.8. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the COF and PPCB stock pages for the full models.
Not investment advice.